These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31514484)

  • 21. Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.
    Nojima M; Matsui T; Tamori A; Kubo S; Shirabe K; Kimura K; Shimada M; Utsunomiya T; Kondo Y; Iio E; Naito Y; Ochiya T; Tanaka Y
    Mol Cancer; 2016 Apr; 15(1):31. PubMed ID: 27137948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of MicroRNAs and target genes involvement in hepatocellular carcinoma with microarray data.
    Wang D; Tan J; Xu Y; Tan X; Han M; Tu Y; Zhu Z; Zen J; Dou C; Cai S
    Hepatogastroenterology; 2015; 62(138):378-82. PubMed ID: 25916067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying Cancer Subtypes from miRNA-TF-mRNA Regulatory Networks and Expression Data.
    Xu T; Le TD; Liu L; Wang R; Sun B; Li J
    PLoS One; 2016; 11(4):e0152792. PubMed ID: 27035433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: study on a chemically-induced HCC mouse model.
    Del Vecchio F; Gallo F; Di Marco A; Mastroiaco V; Caianiello P; Zazzeroni F; Alesse E; Tessitore A
    BMC Bioinformatics; 2015 Dec; 16():408. PubMed ID: 26652480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The RNA expression signature of the HepG2 cell line as determined by the integrated analysis of miRNA and mRNA expression profiles.
    Bai Y; Xue Y; Xie X; Yu T; Zhu Y; Ge Q; Lu Z
    Gene; 2014 Sep; 548(1):91-100. PubMed ID: 25014136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
    Wang JY; Wang CL; Wang XM; Liu FJ
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2114-2129. PubMed ID: 28537673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells.
    Ding M; Li J; Yu Y; Liu H; Yan Z; Wang J; Qian Q
    J Transl Med; 2015 Aug; 13():259. PubMed ID: 26259570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying significant microRNA-mRNA pairs associated with breast cancer subtypes.
    Bhattacharyya M; Nath J; Bandyopadhyay S
    Mol Biol Rep; 2016 Jul; 43(7):591-9. PubMed ID: 27245063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MMiRNA-Viewer
    Bai Y; Baker S; Exoo K; Dai X; Ding L; Khattak NA; Li H; Liu H; Liu X
    BMC Bioinformatics; 2020 Jul; 21(Suppl 4):247. PubMed ID: 32631332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis.
    Yin Y; Shen C; Xie P; Cheng Z; Zhu Q
    Breast; 2016 Apr; 26():1-10. PubMed ID: 27017236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
    Zhan C; Yan L; Wang L; Jiang W; Zhang Y; Xi J; Jin Y; Chen L; Shi Y; Lin Z; Wang Q
    Dis Esophagus; 2016 Nov; 29(8):920-928. PubMed ID: 26402921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
    Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MYC and hsa‑miRNA‑423‑5p as biomarkers in nasopharyngeal carcinoma revealed by miRNA‑mRNA‑pathway network integrated analysis.
    Tian H; Chen S; Zhang C; Li M; Zheng H
    Mol Med Rep; 2017 Aug; 16(2):1039-1046. PubMed ID: 28586063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.
    Chen W; Zhao W; Yang A; Xu A; Wang H; Cong M; Liu T; Wang P; You H
    Gene; 2017 Dec; 636():87-95. PubMed ID: 28919164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of miRNA and mRNA Expression Data for Understanding Etiology of Gynecologic Cancers.
    Paul S
    Methods Mol Biol; 2019; 1912():323-338. PubMed ID: 30635900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis.
    Gao B; Zhang X; Huang Y; Yang Z; Zhang Y; Zhang W; Gao ZH; Xue D
    PLoS One; 2017; 12(3):e0174142. PubMed ID: 28355233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
    Zhang J; Le TD; Liu L; He J; Li J
    Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.